Actively Recruiting

Phase Not Applicable
Age: 18Years - 64Years
All Genders
NCT07166874

The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis

Led by Saglik Bilimleri Universitesi · Updated on 2025-09-10

60

Participants Needed

4

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Subclinical intestinal inflammation and intestinal permeability have been reported in patients with ankylosing spondylitis. Gluten is one of the main triggers of zonulin releaseand gluten intake may contribute to the development of the disease by increasing intestinal permeability. This study aims to determine the impacts of a gluten-freediet on intestinal permeability, sub-clinical intestinal inflammation, disease activity, functional status and quality of life in patients with ankylosing spondylitis. The main questions it aims to answer are: Does a gluten-free diet have an effect on disease activity and functional status in patients with ankylosing spondylitis? Does a gluten-free diet have an effect on intestinal permeability and subclinical intestinal inflammation in patients with ankylosing spondylitis? The investigators will evaluate the effects of the gluten-free diet compared to a control group.

CONDITIONS

Official Title

The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis

Who Can Participate

Age: 18Years - 64Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of axial spondyloarthritis defined by ASAS criteria
  • Adults aged 18 to 64 years
  • Stable treatment with NSAIDs and/or DMARDs for at least 3 months
  • Provided written informed consent and agree to study requirements
Not Eligible

You will not qualify if you...

  • Following any diet currently or within 3 months prior to inclusion
  • History of celiac disease
  • History of Ulcerative Colitis, Crohn's Disease, or Irritable Bowel Syndrome
  • Diagnosis of Type 1 or Type 2 Diabetes Mellitus
  • Diagnosis of Hashimoto Thyroiditis
  • Pregnant or breastfeeding
  • Regular use of omega-3 or vitamins A, C, or E in the past 3 months
  • Body mass index (BMI) less than 18.50 kg/m2
  • Body mass index (BMI) 29.99 kg/m2 or higher

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Bakırköy Dr. Sadi Konuk Training and Research hospital

Istanbul, Turkey (Türkiye)

Actively Recruiting

2

İstanbul Medeniyet University

Istanbul, Turkey (Türkiye)

Active, Not Recruiting

3

İstanbul Sağlık Bilimleri University

Istanbul, Turkey (Türkiye)

Active, Not Recruiting

4

Marmara University

Istanbul, Turkey (Türkiye)

Active, Not Recruiting

Loading map...

Research Team

G

Gülay Sezgin

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here